Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 7 Thoracic 3 Tumor-Agnostic 2 Breast 2 Sarcoma 1 Plasma cell 1 Other 1 Lymphoid 1 Gastrointestinal 1 Dermatologic 1

Conditions

Interventions

Radiotherapy 221 Cyclophosphamide 211 Doxorubicin 210 Temozolomide 182 Ifosfamide 121 Filgrastim 111 Imatinib Mesylate 104 Etoposide 101 Vincristine 92 Gemcitabine 89 Bevacizumab 83 Magnetic Resonance Spectroscopy 81 Irinotecan 79 pembrolizumab 75 Radiation 70 Carboplatin 65 Methotrexate 62 pazopanib 61 Nivolumab 58 Cisplatin 58 fludarabine phosphate 57 Surgical Procedures, Operative 57 Peripheral Blood Stem Cell Transplantation 57 Specimen Handling 56 Trabectedin 52 Docetaxel 50 Biopsy 50 Busulfan 49 Melphalan 46 Paclitaxel 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urine Specimen Collection × Sarcoma × Clear all

NCT06482957 2025-09-19

CAUSAL

Vanderbilt-Ingram Cancer Center

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡